US-Greek R&D-agreement signed
Athens/Napa - Senetek PLC, a US-biopharmaceutical company focused on developing and co-marketing products in the key categories skincare and dermatological worldwide, announced in March that they have signed a cooperative research agreement with two noted researchers in Greece. They are: Dr. Efstathios S. Gonos, Director of Research of the Department of Molecular and Cellular Ageing, Institute of Biological Research and Biotechnology, of the National Hellenic Research Foundation, and his colleague Dr. Ioanna Chinou, Associate Professor of the Division of Pharmacognosy-Chemistry of Natural Products, School of Pharmacy, Athens University. Gonos and Chinou are examining a class of plant extracts and various analogs for their proteasome activation and damaged protein scavenging bioactivity. The agreement gives Senetek exclusive access to all of the Researchers' scientific data within this category and provides for Senetek to participate in funding the testing and development of all selected compounds. The contract also covers the filing and prosecution of new patents covering related inventions, with Senetek having the option to enter into exclusive global licenses under the Researchers' existing patent applications and to jointly develop patents for all future applications.